Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 155

Similar articles for PubMed (Select 21909064)

1.

Management of pemphigus in pediatric patients.

Gürcan H, Mabrouk D, Razzaque Ahmed A.

Minerva Pediatr. 2011 Aug;63(4):279-91. Review.

PMID:
21909064
2.

Current therapy of the pemphigus group.

Kasperkiewicz M, Schmidt E, Zillikens D.

Clin Dermatol. 2012 Jan-Feb;30(1):84-94. doi: 10.1016/j.clindermatol.2011.03.014. Review.

PMID:
22137231
3.

Is it time to re-evaluate the treatment of pemphigus?

Leventhal JS, Sanchez MR.

J Drugs Dermatol. 2012 Oct;11(10):1200-6.

PMID:
23134985
4.

Effect of a single-cycle alternative dosing regimen for rituximab for recalcitrant pemphigus: a case series of 9 patients.

Matsukura S, Knowles SR, Walsh S, Shear NH.

Arch Dermatol. 2012 Jun;148(6):734-9. doi: 10.1001/archdermatol.2011.3320. Erratum in: Arch Dermatol. 2012 Sep 1;148(9):1012. Dosage error in article text. Arch Dermatol. 2012 Aug;148(8):970. Dosage error in article text.

PMID:
22351790
5.

Analysis of current therapy and clinical outcome in childhood pemphigus vulgaris.

Mabrouk D, Ahmed AR.

Pediatr Dermatol. 2011 Sep-Oct;28(5):485-93. doi: 10.1111/j.1525-1470.2011.01514.x. Epub 2011 Aug 23. Review.

PMID:
21883426
6.

Long-term prognosis of pemphigus in Korea: retrospective analysis of 199 patients.

Kim MR, Kim HC, Kim SC.

Dermatology. 2011;223(2):182-8. doi: 10.1159/000332848. Epub 2011 Oct 21.

PMID:
22025028
7.

Steroid sparing effect of intravenous immunoglobulin therapy in patients with pemphigus foliaceus.

Sami N, Qureshi A, Ahmed AR.

Eur J Dermatol. 2002 Mar-Apr;12(2):174-8.

PMID:
11872417
8.

Adjuvant rituximab therapy in pemphigus: a single-center experience of 18 cases.

Baum S, Gilboa S, Greenberger S, Pavlotsky F, Trau H, Barzilai A.

J Dermatolog Treat. 2013 Dec;24(6):427-30. doi: 10.3109/09546634.2013.784391. Epub 2013 May 21.

PMID:
23521340
9.

Corticosteroid-sparing effect of intravenous immunoglobulin therapy in patients with pemphigus vulgaris.

Sami N, Qureshi A, Ruocco E, Ahmed AR.

Arch Dermatol. 2002 Sep;138(9):1158-62.

PMID:
12224976
10.

Treatment of pemphigus vulgaris with rituximab and intravenous immune globulin.

Ahmed AR, Spigelman Z, Cavacini LA, Posner MR.

N Engl J Med. 2006 Oct 26;355(17):1772-9.

11.

First-line combination therapy with rituximab and corticosteroids is effective and safe for pemphigus.

Cho YT, Lee FY, Chu CY, Wang LF.

Acta Derm Venereol. 2014 Jul;94(4):472-3. doi: 10.2340/00015555-1746. No abstract available.

12.

Comparison of immunological parameters in patients with pemphigus vulgaris following rituximab and IVIG therapy.

Feldman RJ, Christen WG, Ahmed AR.

Br J Dermatol. 2012 Mar;166(3):511-7. doi: 10.1111/j.1365-2133.2011.10658.x. Epub 2012 Jan 19.

PMID:
21967407
13.

Rituximab for the treatment of corticosteroid-refractory pemphigus vulgaris with oral and skin manifestations.

Craythorne E, du Viver A, Mufti GJ, Warnakulasuriya S.

J Oral Pathol Med. 2011 Sep;40(8):616-20. doi: 10.1111/j.1600-0714.2011.01017.x. Epub 2011 Mar 9.

PMID:
21385212
14.

Rituximab in childhood pemphigus vulgaris: a long-term follow-up case and review of the literature.

Fuertes I, Guilabert A, Mascaró JM Jr, Iranzo P.

Dermatology. 2010 Aug;221(1):13-6. doi: 10.1159/000287254. Epub 2010 Apr 9. Review.

PMID:
20389028
15.

The actual management of pemphigus.

Daniel BS, Murrell DF.

G Ital Dermatol Venereol. 2010 Oct;145(5):689-702. Review.

PMID:
20930702
16.

[Juvenile pemphigus vulgaris].

Janisson-Dargaud D, Reguiaï Z, Perceau G, Eschard C, Bernard P.

Ann Dermatol Venereol. 2008 Dec;135(12):843-7. doi: 10.1016/j.annder.2007.11.037. Epub 2008 Aug 29. French.

PMID:
19084695
17.

[Pemphigus].

Lapeyre-Liénard H, Joly P.

Presse Med. 2010 Oct;39(10):1066-70. doi: 10.1016/j.lpm.2009.04.016. French.

PMID:
20817387
18.

Rituximab treatment of severe pemphigus: long-term results including immunologic follow-up.

Reguiai Z, Tabary T, Maizières M, Bernard P.

J Am Acad Dermatol. 2012 Oct;67(4):623-9. doi: 10.1016/j.jaad.2011.12.019. Epub 2012 Jan 20.

PMID:
22261417
19.

Analysis of current data on the use of intravenous immunoglobulins in management of pemphigus vulgaris.

Engineer L, Bhol KC, Ahmed AR.

J Am Acad Dermatol. 2000 Dec;43(6):1049-57.

PMID:
11100022
20.

Pemphigus in elderly adults: clinical presentation, treatment, and prognosis.

Ingen-Housz-Oro S, Alexandre M, Le Roux-Villet C, Picard-Dahan C, Tancrède-Bohin E, Wallet-Faber N, Mahé E, Begon E, Francès C, Sigal M, Grootenboer-Mignot S, Aucouturier F, André C, Wolkenstein P, Chosidow O, Prost-Squarcioni C.

J Am Geriatr Soc. 2012 Jun;60(6):1185-7. doi: 10.1111/j.1532-5415.2012.03987.x. No abstract available.

PMID:
22690997
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk